New guidelines have been issued in relation to the management of irritable bowel syndrome and chronic idiopathic constipation. The updated guidelines were published as a supplement to the August issue of the American Journal of Gastroenterology.
Abuse-deterrent properties, identical efficacy for pain relief, reversal of opioid-induced constipation, and theoretical tolerance mitigation may give Targiniq ER an interesting advantage over other oral opioids.
One of the most common treatment courses for chronic pain is comprised of prescription opioid medications. However, concerns about drug addiction and abuse oftentimes outweigh the drugs’ pain-relieving benefits.
Treatment with the oral, peripherally acting µ-opioid receptor antagonist naloxegol is safe and effective for opioid-induced constipation, according to a study published online June 4 in the New England Journal of Medicine.
Administering drops of the probiotic supplement Lactobacillus reuteri protectis in healthy infants results in fewer instances of colic, acid reflux, and constipation compared to placebo.
Following a low-FODMAPs diet reduced symptoms for patients suffering from IBS, according to a study of 38 patients. Unfortunately,the diet might not be realistic for all IBS patients to take on.